within Pharmacolibrary.Drugs.ATC.V;

model V03AB02
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 0.030000000000000002,
    adminDuration  = 600,
    adminMass      = 10 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.002,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>V03AB02</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Nalorphine is a semisynthetic opioid with mixed agonist–antagonist properties. It was historically used as an antidote to opioid overdose and occasionally for pain management or as a diagnostic tool for opioid dependence. However, it is no longer in widespread clinical use today due to the advent of safer and more effective opioid antagonists (such as naloxone).</p><h4>Pharmacokinetics</h4><p>No detailed pharmacokinetic parameters have been published in primary literature for nalorphine in humans. Estimates are based on analogous opioid antagonists and limited secondary sources.</p><h4>References</h4><ol><li><p>Iwamoto, K, &amp; Klaassen, CD (1977). First-pass effect of nalorphine in rats. <i>The Journal of pharmacology and experimental therapeutics</i> 203(2) 365–376. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/909069/\">https://pubmed.ncbi.nlm.nih.gov/909069</a></p></li><li><p>Xie, R, &amp; Hammarlund-Udenaes, M (1998). Blood-brain barrier equilibration of codeine in rats studied with microdialysis. <i>Pharmaceutical research</i> 15(4) 570–575. DOI:<a href=\"https://doi.org/10.1023/a:1011929910782\">10.1023/a:1011929910782</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/9587953/\">https://pubmed.ncbi.nlm.nih.gov/9587953</a></p></li><li><p>Nomof, N, et al., &amp; Parker, KD (1977). Actions and metabolism of codeine (methylmorphine) administration by continuous intravenous infusion to humans. <i>Clinical toxicology</i> 11(5) 517–529. DOI:<a href=\"https://doi.org/10.3109/15563657708988217\">10.3109/15563657708988217</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/608317/\">https://pubmed.ncbi.nlm.nih.gov/608317</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end V03AB02;
